Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Chemmedchem
|
December 11, 2012
N-cyano sulfoximines: COX inhibition, anticancer activity, cellular toxicity, and mutagenicity
Seong Jun Park, Hannah Baars, Stefanie Mersmann, et al.
Antiviral Research
|
April 18, 2025
The conserved core nuclear egress complex (NEC) as an antiherpesviral drug target: Pharmacophore-based identification of NEC-specific inhibitors
Julia Tillmanns, Verena Battisti, Jintawee Kicuntod, et al.
British Journal of Pharmacology
|
June 20, 2006
Chronic 5-HT6 receptor modulation by E-6837 induces hypophagia and sustained weight loss in diet-induced obese rats
Angels Fisas, Xavier Codony, Gonzalo Romero, et al.
Expert Opinion on Pharmacotherapy
|
June 16, 2012
Mechanistic and functional differentiation of tapentadol and tramadol
Robert B Raffa, Helmut Buschmann, Thomas Christoph, et al.
International Immunopharmacology
|
August 17, 2010
Cyclooxygenase-independent inhibitory effects on T cell activation of novel 4,5-dihydro-3 trifluoromethyl pyrazole cyclooxygenase-2 inhibitors
Miguel A Iñiguez, Carmen Punzón, Cristina Cacheiro-Llaguno, et al.
Journal of Medicinal Chemistry
|
March 18, 2005
Synthesis of new benzoxazinone derivatives as neuropeptide Y5 antagonists for the treatment of obesity
Antoni Torrens, Josep Mas, Adriana Port, et al.
European Journal of Pharmacology
|
May 2, 2013
Sigma-1 receptor antagonism as opioid adjuvant strategy: enhancement of opioid antinociception without increasing adverse effects
Alba Vidal-Torres, Beatriz de la Puente, Maria Rocasalbas, et al.
Journal of Medicinal Chemistry
|
July 13, 2012
Synthesis and biological evaluation of the 1-arylpyrazole class of σ(1) receptor antagonists: identification of 4-{2-[5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862)
José Luis Díaz, Rosa Cuberes, Joana Berrocal, et al.
Journal of Medicinal Chemistry
|
March 18, 2005
Medicinal chemistry driven approaches toward novel and selective serotonin 5-HT6 receptor ligands
Jörg Holenz, Ramon Mercè, José Luis Díaz, et al.
Chemmedchem
|
August 8, 2006
A medicinal-chemistry-guided approach to selective and druglike sigma 1 ligands
Jordi Corbera, David Vaño, Daniel Martínez, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Chemmedchem
|
December 11, 2012
N-cyano sulfoximines: COX inhibition, anticancer activity, cellular toxicity, and mutagenicity
Seong Jun Park, Hannah Baars, Stefanie Mersmann, et al.
Antiviral Research
|
April 18, 2025
The conserved core nuclear egress complex (NEC) as an antiherpesviral drug target: Pharmacophore-based identification of NEC-specific inhibitors
Julia Tillmanns, Verena Battisti, Jintawee Kicuntod, et al.
British Journal of Pharmacology
|
June 20, 2006
Chronic 5-HT6 receptor modulation by E-6837 induces hypophagia and sustained weight loss in diet-induced obese rats
Angels Fisas, Xavier Codony, Gonzalo Romero, et al.
Expert Opinion on Pharmacotherapy
|
June 16, 2012
Mechanistic and functional differentiation of tapentadol and tramadol
Robert B Raffa, Helmut Buschmann, Thomas Christoph, et al.
International Immunopharmacology
|
August 17, 2010
Cyclooxygenase-independent inhibitory effects on T cell activation of novel 4,5-dihydro-3 trifluoromethyl pyrazole cyclooxygenase-2 inhibitors
Miguel A Iñiguez, Carmen Punzón, Cristina Cacheiro-Llaguno, et al.
Journal of Medicinal Chemistry
|
March 18, 2005
Synthesis of new benzoxazinone derivatives as neuropeptide Y5 antagonists for the treatment of obesity
Antoni Torrens, Josep Mas, Adriana Port, et al.
European Journal of Pharmacology
|
May 2, 2013
Sigma-1 receptor antagonism as opioid adjuvant strategy: enhancement of opioid antinociception without increasing adverse effects
Alba Vidal-Torres, Beatriz de la Puente, Maria Rocasalbas, et al.
Journal of Medicinal Chemistry
|
July 13, 2012
Synthesis and biological evaluation of the 1-arylpyrazole class of σ(1) receptor antagonists: identification of 4-{2-[5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862)
José Luis Díaz, Rosa Cuberes, Joana Berrocal, et al.
Journal of Medicinal Chemistry
|
March 18, 2005
Medicinal chemistry driven approaches toward novel and selective serotonin 5-HT6 receptor ligands
Jörg Holenz, Ramon Mercè, José Luis Díaz, et al.
Chemmedchem
|
August 8, 2006
A medicinal-chemistry-guided approach to selective and druglike sigma 1 ligands
Jordi Corbera, David Vaño, Daniel Martínez, et al.
Page
of 5